ASMB: Assembly Biosciences Inc Stock Price Quote NASDAQ GS

This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.27% per year. These returns cover a period from January 1, 1988 through April 3, 2023. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations.

• There are currently 2 hold ratings and 1 buy rating for the stock.
• The industry with the worst average Zacks Rank would place in the bottom 1%.
• Historical and current end-of-day data provided by FACTSET.
• As an investor, you want to buy stocks with the highest probability of success.
• Sign-up to receive the latest news and ratings for Assembly Biosciences and its competitors with MarketBeat’s FREE daily newsletter.

© 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer. Upgrade to MarketBeat All Access to add more stocks to your watchlist. One share of ASMB stock can currently be purchased for approximately $1.04. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. ETFMG Treatments Testing and Advancements ETF holds 16,315 shares of ASMB stock, representing 0.07% of its portfolio.

Assembly Biosciences MarketRank™ Forecast

They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Wainwright maintained a Hold rating on Assembly Biosciences (ASMB – Research Report), with a price target of $2.50. The company’s shares closed yesterday at $2.16.According to …

Zacks Research is Reported On:

The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank.

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. CompareASMB’s historical performanceagainst its industry peers and the overall market. Some stocks currently trading in penny stock territory have unique advantages that makes it worthwhile to overlook the inherent risk involved in investing in these stocks. In addition to this technical measure, strong agreement among Wall Stree… BOSTON—-Carver Biosciences, Inc., a biotech company focused on the development of CRISPR/Cas13 antivirals, today announced the formation of its Scientific Advisory Board . 52 week low is the lowest price of a stock in the past 52 weeks, or one year.

Assembly Biosciences saw a increase in short interest in April. As of April 15th, there was short interest totaling 302,700 shares, an increase of 84.5% from the March 31st total of 164,100 shares. Based on an average daily volume of 258,900 shares, the short-interest ratio is presently 1.2 days. Assembly Biosciences’ stock was trading at $1.30 at the beginning of 2023. Since then, ASMB shares have decreased by 20.0% and is now trading at $1.04.

How big is Assembly Biosciences Inc?

Assembly Biosciences Inc 52 week low is $0.77 as of April 29, 2023. 52 week high is the highest price of a stock in the past 52 weeks, or one year. Assembly Biosciences Inc 52 week high is $2.42 as of April 29, 2023.

This is a buy and forget situation I believe as this will take at the least several months to recover. We’d like to share more about how we work and what drives our day-to-day business. Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams.

Assembly Biosciences (ASMB)

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023. Assembly Biosciences has received a 74.27% net impact score from Upright. Assembly Biosciences has a short interest ratio (“days to cover”) of 1.2, which is generally considered an acceptable ratio of short interest to trading volume. According to analysts’ consensus price target of $2.17, Assembly Biosciences has a forecasted upside of 108.3% from its current price of $1.04.

A former bank regulator is blowing the whistle on Biden’s frightening plan to take over your money. Sign-up to receive the latest news and ratings for Assembly Biosciences and its competitors with MarketBeat’s FREE daily newsletter. The P/E ratio of Assembly Biosciences is -0.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. In the past three months, Assembly Biosciences insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $21,108.00 in company stock.

Historical and current end-of-day data provided by FACTSET. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. The heavy selling pressure might have exhausted for Assembly Biosciences as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising…

Assembly Biosciences has been upgraded to a Zacks Rank #1 , reflecting growing optimism about the company’s earnings prospects. Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Morningstar Quantitative ratings for equities are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Intraday Data provided by FACTSET and subject to terms of use.

This https://1investing.in/ is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 . This is a lower news sentiment than the 0.65 average news sentiment score of Medical companies. Assembly Biosciences has received a consensus rating of Hold. The company’s average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies. Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock.

Research Report for ASMB

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share . It can also be calculated by dividing the company’s Market Cap by the Net Profit. Real-time analyst ratings, insider transactions, earnings data, and more. Assembly Biosciences has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts …

On average, they expect the company’s share price to reach $2.17 in the next year. This suggests a possible upside of 108.3% from the stock’s current price. View analysts price targets for ASMB or view top-rated stocks among Wall Street analysts. High-growth stocks tend to represent the technology, healthcare, and communications sectors.

3 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Assembly Biosciences in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should “hold” ASMB shares.

Assembly Biosciences does not have a long track record of dividend growth.

It’s calculated by averaging the closing stock price over the previous 50 trading days. Assembly Biosciences Inc 50-day moving average is $1.14. According to 3 analysts, the average rating for ASMB stock is “Buy.” The 12-month stock price forecast is $2.17, which is an increase of 108.65% from the latest price. We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. 3 brokerages have issued twelve-month target prices for Assembly Biosciences’ stock. Their ASMB share price forecasts range from $1.50 to $3.00.

• Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
• And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
• Style is an investment factor that has a meaningful impact on investment risk and returns.
• MarketBeat has tracked 35 news articles for Assembly Biosciences this week, compared to 18 articles on an average week.
• The P/E ratio of Assembly Biosciences is -0.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data. ASMB does not currently have a forward dividend yield. There may be delays, omissions, or inaccuracies in the Information.

Other comex data may be delayed by 15 minutes or more. EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. The technique has proven to be very useful for finding positive surprises.